• 7408 malaria professionals are enjoying the free benefits of MalariaWorld today

Republic of Korea

Genetic diversity of the malaria vaccine candidate merozoite surface protein 1 gene of Plasmodium vivax field isolates in Republic of Korea

Author(s): 
Eun-Taek Han, Yue Wang, Chae Seung Lim, Jun Hwi Cho & Jong-Yil Chai
Reference: 
Parasitology Research, Volume 109, Number 6, 1571-1576, DOI: 10.1007/s00436-011-2413-5
Contact email: 
ethan@kangwon.ac.kr

MalariaWorldThe Plasmodium vivax merozoite surface protein 1 (Pvmsp-1) locus codes for a major asexual blood-stage antigen currently proposed as a malaria vaccine candidate antigen.

Short Report: Therapeutic Efficacy of Chloroquine in Plasmodium vivax and the pvmdr1 Polymorphisms in the Republic of Korea Under Mass Chemoprophylaxis

Author(s): 
Young Keun Kim, Changsoo Kim, Inho Park, Hyo Youl Kim, Jun Yong Choi, AND June Myung Kim
Reference: 
Am J Trop Med Hyg, Apr 2011; 84: 532 - 534.
Contact email: 
amoxj@yonsei.ac.kr

We investigated the therapeutic efficacy of HCQ and the pvmdr1 gene polymorphisms in P. vivax. From June to September 2006, 102 soldiers with vivax malaria near the demilitarized zone in Gyeonggi-do, ROK, were enrolled in the study.

Brief report: Emergence of New Alleles of the MSP-3{alpha} Gene in Plasmodium vivax Isolates from Korea

Author(s): 
Deok Hwa N., Jun Seo O., et al.
Reference: 
American Journal of Tropical Medicine Hygiene, Vol 82 : 4, 2010, pp. 522-524
Contact email: 
malarim@korea.ac.kr

Two new variants with similar size to SKOR-67 were first observed in 2002 and in 2006–2007 accounted for nearly 50% (25/51) of the sampled isolates.

Syndicate content